Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
June 30 2022 - 2:33PM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
confirmed that it has received an unsolicited, non-binding proposal
from Kennedy Lewis Investment Management LLC to acquire all of the
outstanding shares of the Company for $5.00 per share in cash.
Consistent with its fiduciary duties and in consultation with
its independent advisors, the Rapid Micro Biosystems Board of
Directors will carefully review the unsolicited proposal to
determine the course of action that it believes is in the best
interest of the Company and all Rapid Micro Biosystems
shareholders. Rapid Micro Biosystems shareholders do not need to
take any action at this time.
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology
company providing mission critical automation solutions to
facilitate the efficient manufacturing and fast, safe release of
healthcare products such as biologics, vaccines, cell and gene
therapies, and sterile injectables. The Company’s flagship Growth
Direct system automates and modernizes the antiquated, manual
microbial quality control (“MQC”) testing workflows used in the
largest and most complex pharmaceutical manufacturing operations
across the globe. The Growth Direct system brings the quality
control lab to the manufacturing floor, unlocking the power of
in-line/at-the-line MQC automation to deliver faster results,
greater accuracy, increased operational efficiency, better
compliance with data integrity regulations, and quicker decision
making, that customers rely on to ensure safe and consistent supply
of important healthcare products. The Company is headquartered and
has U.S. manufacturing in Lowell, Massachusetts, with global
locations in Lexington, Massachusetts, Switzerland, Germany, and
the Netherlands. For more information, please visit
www.rapidmicrobio.com or follow the Company on Twitter at
@rapidmicrobio or on LinkedIn.
Forward Looking Statements
This press release may contain “forward-looking statements”
within the meaning of the federal securities laws. Such statements
are identified by use of the words “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,”
“should,” and similar expressions that do not relate to historical
matters. Any forward-looking statements contained herein are based
on current expectations, but are subject to risks and uncertainties
that could cause actual results to differ materially from those
indicated, including, but not limited to, those risks and
uncertainties detailed from time to time in Rapid Micro Biosystems’
filings with the U.S. Securities and Exchange Commission. Rapid
Micro Biosystems does not undertake a duty to update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise.
Contacts:
Investors
Michael Beaulieu
CFA Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com
Media
Jamie Moser / Lucas Pers
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Apr 2024 to May 2024
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From May 2023 to May 2024